Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

African Countries Adopt Treaty To Set Up New Medicines Agency

Executive Summary

African health ministers have agreed on a treaty to set up a new pan-African agency to coordinate regional drug regulatory harmonization initiatives and pool limited regulatory expertise.

You may also be interested in...



New Deal To Boost Progress On African Medicines Agency

A new agreement between the WHO and the African Union is expected to strengthen efforts to create the new African Medicines Agency, following the endorsement of the AMA treaty earlier this year.

Denmark Signs Up To WHO’s Regulatory Strengthening Project

Thomas Senderovitz, head of the Danish Medicines Agency and chair of the EU’s Heads of Medicines Agencies, talks to the Pink Sheet about his agency’s agreement with the WHO on strengthening regulatory agencies in lower income countries, and why it is the “obvious thing to do.”

Latin America Inches Towards Greater Regulatory Harmonization

Regulatory harmonization is gathering pace in Latin America, which is good news for pharmaceutical companies.

Related Content

Topics

UsernamePublicRestriction

Register

ID1128360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel